Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|August 25, 2021
[Cardiovascular risk and type 1 diabetes]Alexandre Dondonne, Nicolas Paquot, Karine Fombellida, et al.
Infectious Disease Reports|March 25, 2024
Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022Damien Scaia, Karine Fombellida, Nathalie Maes, et al.
Frontiers in Pharmacology|October 8, 2025
Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in BelgiumVictoria Lopez Delhoulle, Li-Cécile Destordeur, Nathalie Maes, et al.
HIV Research & Clinical Practice|July 26, 2021
Impact of the COVID-19 pandemic situation on HIV care in Liège, BelgiumMajdouline El Moussaoui, Nicolas Lambert, Nathalie Maes, et al.
Open Forum Infectious Diseases|September 5, 2025
Factors Contributing to Pneumococcal, COVID-19, and Influenza Vaccine Uptake Among People Living With HIV in Belgium: A Retrospective StudyLi-Cécile Destordeur, Victoria Lopez Delhoulle, Iraklis Papadopoulos, et al.
Scientific Reports|June 7, 2018
Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017Gilles Darcis, Iseult Lambert, Anne-Sophie Sauvage, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2019
Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral TherapyGilles Darcis, Nathalie Maes, Alexander O Pasternak, et al.
Open Forum Infectious Diseases|November 18, 2020
Evolution of Drug Interactions With Antiretroviral Medication in People With HIVMajdouline El Moussaoui, Iseult Lambert, Nathalie Maes, et al.
Acta Clinica Belgica|June 18, 2017
Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective studyJessie Gunter, Steven Callens, Stephane De Wit, et al.
Pageof 2